Impact BioMedical, Inc. (IBO) is a publicly traded Healthcare sector company. As of August 7, 2026, IBO trades at $0.44 with a market cap of $48.61M and a P/E ratio of -1.16. IBO moved -3.48% today. Year to date, IBO is -16.08%; over the trailing twelve months it is -25.99%. Its 52-week range spans $0.36 to $6.17. Rallies surfaces IBO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $0.44 |
| Market Cap | $48.61M |
| P/E Ratio | -1.16 |
| EPS | $-0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.17 |
| 52-Week Low | $0.36 |
| Volume | 9.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.87M |
| Gross Margin | 0.00% |
IBO analyst coverage data. Average price target: $0.00.